{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:45:54Z","timestamp":1792205154356,"version":"4.4.0"},"reference-count":12,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T00:00:00Z","timestamp":1133827200000},"content-version":"vor","delay-in-days":8375,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[1983,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adenine arabinoside monophosphate (ARA AMP) was used in ten immunosuppressed patients suffering from varicella or disseminated zoster, and compared to adenine arabinoside (vidarabine) in ten other similar patients. Good results were obtained with both drugs: the fever stopped suddenly in three or four days and no new vesicles were observed after the third day. ARA AMP is more soluble than vidarabine and is thus easier to handle; it could be an effective treatment of severe varicella\u2010zoster virus infections in immunosuppressed patients.<\/jats:p>","DOI":"10.1002\/jmv.1890120209","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T11:40:14Z","timestamp":1172835614000},"page":"149-153","source":"Crossref","is-referenced-by-count":10,"title":["Comparative use of adenine arabinoside and adenine arabinoside monophosphate in varicella and disseminated zoster in immunosuppressed patients"],"prefix":"10.1002","volume":"12","author":[{"given":"J. L.","family":"Vilde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bricaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Huchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Brun\u2010Vezinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,12,6]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.9.3.540"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/131.3.225"},{"key":"e_1_2_1_4_1","first-page":"237","volume-title":"Adenine\u2010Arabinoside: An Antiviral Agent","author":"Luby JP","year":"1975"},{"key":"e_1_2_1_5_1","first-page":"2725","article-title":"Effet de deux nucl\u00e9osides de l'ad\u00e9nine arabinoside sur la multiplication des virus de l'herp\u00e9s et de la vaccine en culture cellulaire","volume":"259","author":"de Garilhe M","year":"1964","journal-title":"Compte\u2010rendus de l'Acad\u00e9mie des Sciences"},{"key":"e_1_2_1_6_1","first-page":"1","volume-title":"Adenine\u2010Arabinoside: An Antiviral Agent","author":"Shannon WM","year":"1975"},{"key":"e_1_2_1_7_1","first-page":"45","volume-title":"Adenine\u2010Arabinoside: An Antiviral Agent","author":"Sloan BJ","year":"1975"},{"key":"e_1_2_1_8_1","volume-title":"Proceedings of the 11th International Congress of Chemotherapy","author":"Tyrrell DJL","year":"1979"},{"key":"e_1_2_1_9_1","volume-title":"Proceedings of the 21st Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"Vilde J\u2010L","year":"1981"},{"key":"e_1_2_1_10_1","first-page":"3457","article-title":"Traitement par l'ad\u00e9nine\u2010arabinoside des varicelles et zonas g\u00e9n\u00e9ralis\u00e9s chez 43 malades immunod\u00e9prim\u00e9s","volume":"11","author":"Vilde J\u2010L","year":"1982","journal-title":"Nouvelle Presse M\u00e9dicale"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197605272942201"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-197704000-00837"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.18.5.709"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.1890120209","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.1890120209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T21:46:07Z","timestamp":1697751967000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.1890120209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,1]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1983,1]]}},"alternative-id":["10.1002\/jmv.1890120209"],"URL":"https:\/\/doi.org\/10.1002\/jmv.1890120209","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,1]]}}}